JohnCLamattinaMD
General Surgery • Chicago, ILTransplantation
Assistant Professor, Surgery, University of Maryland School of Medicine
Are you Dr. Lamattina?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 67 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200
Summary
- Dr. John Lamattina, MD is a general surgeon in Chicago, Illinois. He is currently licensed to practice medicine in Illinois, Alaska, and West Virginia. He is affiliated with University of Chicago Medical Center and is an Assistant Professor at University of Maryland School of Medicine.
Education & Training
Massachusetts General HospitalResidency, Surgery, 2003 - 2008
Harvard Medical SchoolClass of 2003
Certifications & Licensure
IL State Medical License 2020 - 2026
WI State Medical License 2008 - 2025
AK State Medical License 2019 - 2024
MD State Medical License 2010 - 2022
WV State Medical License 2014 - 2022- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow American College of Surgeons
Publications & Presentations
PubMed
- 1 citationsComparing High- and Low-Model for End-Stage Liver Disease Living-Donor Liver Transplantation to Determine Clinical Efficacy: A Systematic Review and Meta-Analysis (CHA...Kumar Jayant, Thomas G Cotter, Isabella Reccia, Francesco Virdis, Mauro Podda
Journal of Clinical Medicine. 2023-09-06 - 1 citationshEPCR.hTBM.hCD47.hHO-1 with donor clodronate and DDAVP treatment improves perfusion and function of GalTKO.hCD46 porcine livers perfused with human blood.Arielle Cimeno, Kasinath Kuravi, Lori Sorrells, Amy Dandro, Selin Sendil
Xenotransplantation. 2022-03-01 - 6 citationsIschemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters.Naeem Goussous, Josue Alvarez-Casas, Noor Dawany, Wen Xie, Saad Malik
Transplantation Direct. 2022-01-01
Authored Content
- Pfizer Should Be Wary About Covid-19 Vaccine Price HikesFebruary 2021
Press Mentions
Vedanta Biosciences Closes $50 Million Financing to Advance Microbiome TherapeuticsJune 6th, 2016- Vedanta Biosciences Announces License Agreement with RIKEN and Other Japanese Institutions for New Immune Boosting Microbiome TechnologyApril 14th, 2016
- Vedanta Biosciences Appoints New Chief Scientific Officer and Expands to New FacilityMarch 16th, 2016
Professional Memberships
- Member
